Variables | ICG group (n = 52) | Control group (n = 57) | P value |
Male:Female | 33:19 | 26:31 | 0.062 |
Age (years) | 61.85 ± 9.82 | 62.21 ± 11.45 | 0.861 |
ASA score (≥3) | 35 (67.31%) | 34 (59.65%) | 0.407 |
BMI (≥25 kg/m2) | 15 (28.85%) | 20 (35.09%) | 0.486 |
Clinical T status 3 - 4 | 41 (78.85%) | 44 (77.19%) | 0.835 |
Smoking history | 17 (32.69%) | 13 (22.81%) | 0.248 |
Diabetes | 6 (11.54%) | 4 (7.02%) | 0.514 |
Neoadjuvant therapy | 5 (9.62%) | 5 (8.77%) | 0.879 |
Previous abdominal surgery | 10 (19.23%) | 11 (19.30%) | 0.993 |
Tumor distance from anal verge (cm) | 7.91 ± 3.30 | 8.12 ± 3.29 | 0.740 |